Demystify Meds for Moderate to Severe Crohn’s Disease

August 2023

There’s a growing number of meds for Crohn’s disease...especially now that Rinvoq (upadacitinib) is in the mix.

This “Janus kinase (JAK) inhibitor” is already approved for rheumatoid arthritis...ulcerative colitis...and other conditions.

Now Rinvoq is the first oral once-daily med indicated for moderate to severe Crohn’s disease.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Address Issues With Shipping or Delivering Rxs
Geriatrics Look Out for Older Patients Getting Potentially Risky Meds
Menopause Watch for Veozah, a New Rx for Hot Flashes
Med Safety Support Safe Use of Stimulants
Cultural Awareness Use Inclusive Language to Reduce Stigma
Testosterone Prevent Mix-Ups With Testosterone Products
Crohn Disease Demystify Meds for Moderate to Severe Crohn’s Disease
Opioids Help Ensure Opioid Switches Go Smoothly
NatMed Spotlight Be Prepared With Answers About Milk Thistle